DiaMedica Inc  

(Public, CVE:DMA)   Watch this stock  
Find more results for DMA
-0.010 (-4.76%)
Oct 21 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.19 - 0.20
52 week 0.09 - 0.35
Open 0.20
Vol / Avg. 125,000.00/89,172.00
Mkt cap 21.06M
P/E     -
Div/yield     -
EPS -0.03
Shares 110.33M
Beta -0.18
Inst. own     -

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -518.62% -629.99%
Return on average equity - -
CDP Score - -


1 Carlson Pkwy N Ste 124
MINNEAPOLIS, MN 55447-4453
United States - Map
+1-763-2700603 (Phone)
+1-763-7104456 (Fax)

Website links


DiaMedica Inc. is a clinical-stage biopharmaceutical company, which focuses on recombinant proteins and monoclonal antibodies. The Company focuses on the discovery and development of treatments for stroke and other vascular diseases. It operates through segment, which is discovery and development of recombinant proteins and monoclonal antibody technology applications to treat large unmet diseases, including acute vascular disease of the brain, kidneys and heart. Its product, DM199, is a recombinant human tissue kallikrein-1 protein engineered to duplicate the actions of the naturally occurring human kallikrein-1 protein produced in the pancreas, kidneys and salivary glands of humans as a response to oxidative stress challenges. Its drug, Recombinant tissue plasminogen activator, is intended for the treatment of acute ischemic stroke (AIS). DM199 has also completed a Phase I/II clinical trials in Type 2 diabetic patients.

Officers and directors

Richard D. Pilnik Independent Chairman of the Board
Age: 57
Rick Pauls President, Chief Executive Officer, Director
John Savage CPA Chief Financial Officer
Todd A. Verdoorn Ph.D. Chief Scientific Officer
David Aaron Gurvey Vice President - Finance
Mark Williams Ph.D. Vice President - Research
Dennis D. Kim M.D. Consulting Chief Medical Officer
Age: 46
Uger T. Parsons CPA Corporate Secretary, Director
Michael Giuffre M.D. Independent Director
Dawson J. Reimer Independent Director
Age: 45